Polymorphisms in TRAIL receptor genes and risk of breast cancer in Spanish women

Cancer Biomarkers

Volumn 3, Issue 2, 2007, Pages 89-93

  Martinez Ferrandis, José I ^a,b   Rodríguez López, Raquel ^c   Milne, Roger L ^c   González, Emilio ^c   Cebolla, Elvira ^a   Chirivella, Isabel ^d   Zamora, Pilar ^e   Arias, José I ^f   Palacios, Santiago ^g   Cervantes, Andrés ^d   Díez, Orland ^b   Benitez, Javier ^c   Armengod, M Eugenia ^a  

^a CENTRO DE INVESTIGACIÓN PRÍNCIPE FELIPE   (Spain)

^b Hospital Sant Pau   (Spain)

^c Centro Nacional de Investigaciones Oncológicas   (Spain)

^d HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^e HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^f HOSPITAL MONTE NARANCO   (Spain)

^g Instituto Palacios de Salud Y Medicina de la Mujer   (Spain)

Author keywords

Apoptosis; Breast cancer risk; Polymorphisms; Trail receptors

Indexed keywords

ADENINE; CYTOSINE; DEATH RECEPTOR; DEATH RECEPTOR 4; DEATH RECEPTOR 5; DECOY RECEPTOR 2; GUANINE; MESSENGER RNA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR 3; UNCLASSIFIED DRUG; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR;

3' UNTRANSLATED REGION; ADULT; AGED; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE LOCATION; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK REDUCTION; RNA STABILITY; SINGLE NUCLEOTIDE POLYMORPHISM; SPAIN; AGE; BREAST TUMOR; GENETICS; MIDDLE AGED; POLYMERASE CHAIN REACTION;

ADULT; AGE FACTORS; AGED; BREAST NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; SPAIN;

EID: 34447279450     PISSN: 15740153     EISSN: None     Source Type: Journal    
DOI: 10.3233/CBM-2007-3203     Document Type: Article

References (11)

1. D.D. Easton, How many more breast cancer predisposition genes are there? Cancer Res 1 (1999), 14-17.
2. P.D.P. Pharoah, A. Antonion, M. Bobrow, R.L. Zimmern, D.F. Easton and B.A.J. Ponder, Polygenic susceptibility to breast cancer and implications for prevention, Nature Genet 31 (2002), 33-36.
3. H. Yagita, K. Takeda, Y. Hayakawa, M.J. Smyth and K. Okumura, TRAIL and its receptors as targets for cancer therapy, Cancer Sci 95 (2004), 777-783.
4. S. Seitz, P. Wassmuth, J. Fischer, A. Nothnagel, B. Jandrig, P.M. Schlag and S. Scherneck, Mutation analysis and mRNA expression of trail-receptors in human breast cancer, Int J Cancer 102 (2002), 117-128.
5. V. Fernandez, P. Jares, S. Bea, I. Salaverria, E. Guino, S. de Sanjose, D. Colomer, G. Ott, E. Montserrat and E. Campo, Frequent polymorphic changes but not mutations of TRAIL receptors DR4 and DR5 in mantle cell lymphoma and other B-cell lymphoid neoplasms, Haematologica 89 (2004), 1322-1331.
6. M.J. Fisher, A.K. Virmani, L. Wu, R. Aplene, J.C. Harper, S.M. Powell, T.R. Rebbeck, D. Sidransky, A.F. Gazdar and W.S. El-Deiry, Nucleotide substitution in the ectodomain of trail receptor DR4 is associated with lung cancer and head and neck cancer, Clin Cancer Res 7 (2001), 1688-1697.
7. K. Kim, M.J. Fisher, S.Q. Xu and W.S. El-Deiry, Molecular determinants of rosponse to TRAIL in killing of normal and cancer cells, Clin Cancer Res 6 (2000), 335-346.
8. Horak, D. Pils, M. Roessler, S. Tomek, K. Elandt, R. Zeillinger, C. Zielinski and M. Krainer, Common death receptor 4 (DR4) polymorphisms do not predispose to ovarian cancer, Gynecol Oncol 97 (2005), 514-518.
9. G. MacPherson, C.S. Healey, M.D. Teare, S.P. Balasubramanian, M.W.R. Reed, P.D.P. Pharoah, B.A. Ponder, M. Meuth, N.P. Bhattacharyya and A. Cox, Association of a common variant of the CASP8 gene with reduced risk of breast cancer, J Nalt Cancer Inst 96 (2004), 1866-1869.
10. B. Frank, K. Hemminki, K.S. Shanmugan, A. Meindl, R. Klaes, R.K. Schutzler, B. Wappensschmidt, M. Untch, P. Bugert, C.R. Bartram and B. Burwinkel, Association of death receptor 4 haplotype 626C-683C with an increased breast cancer risk, Carcinogenesis 26 (2005), 1975-1977.
11. F. Rubio-Moscardo, D. Blesa, C. Mestre, R. Siebert, T. Balasas, A. Benito, A. Rosenwald, J. Climent, J.I. Martinez, M. Schilhabel, E.L.Karran, S. Gesk, M. Esteller, R. deLeeuw, L.M. Staudt, J.L. Fernandez-Luna, D. Pinkel, M.J. Dyer and J.A. Martinez-Climent, Characterization of 8p21.3 chromosomal deletions in B-cell lymphoma: TRAIL-R1 and TRAIL-R2 as candidate dosage-dependent tumor suppressor genes, Blood 106 (2005), 3214-3222.